Steven Cohen’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.7M Buy
280,200
+275,172
+5,473% +$33.2M 0.03% 713
2026
Q2
$670K Sell
5,028
-632,708
-99% -$71.6M ﹤0.01% 3038
2026
Q1
$71M Sell
637,736
-1,771,418
-74% -$210M 0.09% 253
2025
Q4
$325M Sell
2,409,154
-516,198
-18% -$56.3M 0.36% 25
2025
Q3
$248M Buy
2,925,352
+2,757,465
+1,642% +$169M 0.42% 33
2025
Q2
$1.28M Buy
167,887
+138,469
+471% +$903K ﹤0.01% 1466
2025
Q1
$184K Sell
29,418
-61,882
-68% -$419K ﹤0.01% 1836
2024
Q4
$668K Sell
91,300
-451,600
-83% -$4.16M ﹤0.01% 1581
2024
Q3
$6.25M Buy
542,900
+119,300
+28% +$1.43M 0.02% 809
2024
Q2
$5.6M Buy
423,600
+600
+0.1% +$8.58K 0.01% 805
2024
Q1
$6.05M Buy
423,000
+3,600
+0.9% +$46.4K 0.01% 905
2023
Q4
$4.49M Buy
+419,400
New +$4.27M 0.01% 965

Other funds holding ABVX

Steven Cohen's ABVX Position: Q3 2026 in Review

Steven Cohen increased its Abivax (ABVX) stake by 5,473% in Q3 2026, buying an estimated $33.2M and bringing the position to 280,200 shares worth $27.7M. The position accounts for 0.03% of the portfolio, ranked #713.

Steven Cohen first reported a position in ABVX in Q4 2023 and has held it in 12 quarters since. The position peaked at $325M in Q4 2025. 318 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Steven Cohen held 280,200 shares of Abivax worth $27.7M as of Q3 2026.
  • Steven Cohen bought 275,172 Abivax shares in Q3 2026, an estimated $33.2M.
  • Abivax made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #713 holding.
  • Steven Cohen first reported a position in Abivax in Q4 2023 and has held it in 12 quarters since.
  • Steven Cohen's Abivax position peaked at $325M in Q4 2025.
  • 318 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.